Bengaluru doctor with double kidney transplant takes jab, backs it
Dr AP Nirmal Raj pointed out he took the Covid vaccine on January 17. “I’m taking anti-diabetic, cholesterol drugs and have undergone angioplasty earlier. People with comorbidities must not fear the vaccine,” he said. (Source: The Economic Times)
Source: The Economic Times - January 24, 2021 Category: Consumer Health News Source Type: news

Time to Angioplasty Is Crucial for Better Heart Attack Outcomes
Title: Time to Angioplasty Is Crucial for Better Heart Attack OutcomesCategory: Health NewsCreated: 1/14/2021 12:00:00 AMLast Editorial Review: 1/15/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - January 15, 2021 Category: Cardiology Source Type: news

Time to Angioplasty Is Crucial for Better Heart Attack Outcomes
  THURSDAY, Jan. 14, 2021 -- When a heart attack begins, the time it takes until the blockage in a coronary artery is cleared is critical in preventing further damage to the heart, a new study warns. The amount of damage is directly related... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 14, 2021 Category: General Medicine Source Type: news

Symptom-to-Balloon Time Linked to Infarct Size in STEMI
THURSDAY, Jan. 14, 2021 -- For patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI), symptom-to-balloon time (SBT), but not door-to-balloon time (DBT), is associated with... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 14, 2021 Category: Pharmaceuticals Source Type: news

What Is the Difference Between Angiogram and Angioplasty?
Title: What Is the Difference Between Angiogram and Angioplasty?Category: Diseases and ConditionsCreated: 1/12/2021 12:00:00 AMLast Editorial Review: 1/12/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - January 12, 2021 Category: Cardiology Source Type: news

Physician-Level PCI Mortality Data May Be Misleading Physician-Level PCI Mortality Data May Be Misleading
Percutaneous coronary intervention mortality data do not adequately reflect the quality of care delivered by cardiologists who perform this procedure at multiple centers, researchers report.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - January 4, 2021 Category: Intensive Care Tags: Cardiology News Source Type: news

Boston Scientific Withdraws Lotus Edge ™ from Market
Originally designed as a unique aortic valve system that could be repositioned and retrieved, the Lotus ™ Valve System is now also recalled. On Tuesday, Boston Scientific announced "global, voluntary recall of all unused inventory of the LOTUS Edge™ Aortic Valve System due to complexities associated with the product delivery system." (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - November 21, 2020 Category: Cardiology Source Type: news

Clopidogrel Bests Ticagrelor for Elective PCI Clopidogrel Bests Ticagrelor for Elective PCI
Ticagrelor failed to unseat clopidogrel as the guideline-recommended P2Y12 inhibitor of choice in patients undergoing elective percutaneous coronary intervention for stable CAD in the randomized ALPHEUS trial.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 15, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Marijuana Raises Post-Op Dangers After Heart Attack
Marijuana smokers are more likely to suffer complications like excess bleeding or stroke if they undergo angioplasty to reopen clogged arteries, a University of Michigan-led study found. (Source: WebMD Health)
Source: WebMD Health - November 10, 2020 Category: Consumer Health News Source Type: news

IN.PACT BTK: Step in the Right Direction for DCB in Below-Knee CLI IN.PACT BTK: Step in the Right Direction for DCB in Below-Knee CLI
The phase 2 study showed late lumen loss comparable to or better than angioplasty, with no safety signal in a space primed for new treatments.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 20, 2020 Category: Consumer Health News Tags: Cardiology News Source Type: news

Results from the TARGET FFR study reported at TCT Connect
(Cardiovascular Research Foundation) Results from the randomized controlled TARGET FFR trial show that while a physiology-guided percutaneous coronary intervention (PCI) optimization strategy did not achieve a significant increase in the proportion of patients with final FFR ?0.90, it reduced the proportion of patients with a residual FFR ?0.80 following PCI. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 16, 2020 Category: International Medicine & Public Health Source Type: news

DISRUPT CAD III Meets all Endpoints in U.S. Pivotal Study for Coronary Intravascular Lithotripsy
The Shockwave Coronary IntraVascular Lithotripsy (IVL) System has been available in Europe for more than 2 years, but to receive U.S. approval, it needed to show safety and efficacy in a trial specifically designed to meet FDA requirements. Today the 30-day results of the DISRUPT CAD III were presented by Dr. Dean Kereiakes at TCTConnect, the online virtual version of the annual Transcatheter Cardiovascular Therapeutics meeting, and the device met all endpoints, moving it closer to approval for the U.S. market. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - October 15, 2020 Category: Cardiology Source Type: news

Medtronic Resolute Onyx ™ Drug Eluting Stent (DES) First to Receive One-Month DAPT Labeling in the U.S. with Expanded Indication for High Bleeding Risk Patients
Medtronic plc (NYSE:MDT) today announced it has received U.S. Food and Drug Administration (FDA) approval for new one-month of dual-antiplatelet therapy (DAPT) labeling with an expanded indication for high bleeding risk (HBR) patients implanted with the Resolute Onyx ™ DES. The Resolute Onyx DES is the first-and-only DES in the U.S. that has been proven safe and effective utilizing a one-month regimen of DAPT – the combination of aspirin and an anti-clotting medication – following a percutaneous coronary intervention (PCI) in patients at high bleeding risk . (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - October 1, 2020 Category: Cardiology Source Type: news

CYP2C19 Genotyping May Aid Antiplatelet Prescribing
WEDNESDAY, Sept. 9, 2020 -- Genotyping may provide some clinical benefit in prescribing antiplatelet therapies for patients undergoing percutaneous coronary intervention (PCI), according to a study published in the Aug. 25 issue of the Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 9, 2020 Category: Pharmaceuticals Source Type: news

International registries show PCI rates increased in Japan, US
(American College of Cardiology) Japan and the US have seen an increase in percutaneous coronary intervention (PCI) procedures, which is driven primarily by a rise in elective PCIs in Japan compared to non-elective in the U.S., according to a study in the Journal of the American College of Cardiology. Since adoption of large-scale PCI trial results vary internationally, the study sought to analyze large national registries in both countries to illuminate international variation in PCI practice as a foundation for further quality improvement. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 7, 2020 Category: International Medicine & Public Health Source Type: news